BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18627387)

  • 1. Tufted hair folliculitis in a woman treated with lapatinib for breast cancer.
    Ena P; Fadda GM; Ena L; Farris A; Santeufemia DA
    Clin Exp Dermatol; 2008 Nov; 33(6):790-1. PubMed ID: 18627387
    [No Abstract]   [Full Text] [Related]  

  • 2. Tufted hair folliculitis in a woman treated with trastuzumab.
    Rosman IS; Anadkat MJ
    Target Oncol; 2010 Dec; 5(4):295-6. PubMed ID: 20949375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folliculitis decalvans associated with erlotinib.
    Hoekzema R; Drillenburg P
    Clin Exp Dermatol; 2010 Dec; 35(8):916-8. PubMed ID: 20456379
    [No Abstract]   [Full Text] [Related]  

  • 4. Tracheal granuloma pyogenicum with erlotinib treatment for lung cancer.
    Putora PM; Benz G; Rodriguez R; Brutsche M; Früh M
    Eur Respir J; 2011 Nov; 38(5):1228-30. PubMed ID: 22045792
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer.
    Spraggs CF; Budde LR; Briley LP; Bing N; Cox CJ; King KS; Whittaker JC; Mooser VE; Preston AJ; Stein SH; Cardon LR
    J Clin Oncol; 2011 Feb; 29(6):667-73. PubMed ID: 21245432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of gefitinib-associated folliculitis.
    Matheis P; Socinski MA; Burkhart C; Warren S; Thomas NE
    J Am Acad Dermatol; 2006 Oct; 55(4):710-3. PubMed ID: 17010757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute paronychia caused by lapatinib therapy.
    Rigopoulos D; Gregoriou S; Belyayeva Y; Larios G; Gkouvi A; Katsambas A
    Clin Exp Dermatol; 2009 Jan; 34(1):94-5. PubMed ID: 19076807
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyogenic Granuloma in a Patient on Gefitinib.
    Massa A; Antunes A; Varela P
    Acta Med Port; 2016 Jun; 29(6):416. PubMed ID: 27865223
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenol 8% solution for the treatment of epidermal growth factor receptor inhibitor-induced periungual pyogenic granulomas.
    Panariello L; Caro G; Bianca D; Fabbrocini G
    G Ital Dermatol Venereol; 2015 Dec; 150(6):755-6. PubMed ID: 26513046
    [No Abstract]   [Full Text] [Related]  

  • 10. Gefitinib: a cause of pyogenic granulomalike lesions of the nail.
    High WA
    Arch Dermatol; 2006 Jul; 142(7):939. PubMed ID: 16847224
    [No Abstract]   [Full Text] [Related]  

  • 11. Erlotinib associated with rosacea-like folliculitis and Malassezia sympodialis.
    Cuétara MS; Aguilar A; Martin L; Aspiroz C; del Palacio A
    Br J Dermatol; 2006 Aug; 155(2):477-9. PubMed ID: 16882195
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse reactions to gefitinib (Iressa): revealing sycosis- and pyoderma gangrenosum-like lesions.
    Sagara R; Kitami A; Nakada T; Iijima M
    Int J Dermatol; 2006 Aug; 45(8):1002-3. PubMed ID: 16911406
    [No Abstract]   [Full Text] [Related]  

  • 13. Pyogenic granuloma caused by afatinib: Case report and review of the literature.
    Inoue A; Sawada Y; Nishio D; Nakamura M
    Australas J Dermatol; 2017 Feb; 58(1):61-62. PubMed ID: 26603180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of pyogenic granulomas following gefitinib therapy with partial matricectomy and phenolization.
    Dika E; Balestri R; Vaccari S; Alessandro Fanti P; Misciali C; Patrizi A
    J Dermatolog Treat; 2009; 20(6):374-5. PubMed ID: 19954397
    [No Abstract]   [Full Text] [Related]  

  • 15. Social and cultural dimensions of hair loss in women treated for breast cancer.
    Freedman TG
    Cancer Nurs; 1994 Aug; 17(4):334-41. PubMed ID: 7525048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic distribution of lapatinib-induced skin rash: sparing of abdominal skin persists in the transverse rectus abdominis myocutaneous flap.
    Lin NU; Kasparian E; Morganstern DE; Beard C
    J Clin Oncol; 2009 Dec; 27(34):e218-9. PubMed ID: 19786662
    [No Abstract]   [Full Text] [Related]  

  • 17. Massive tufted hair folliculitis associated with chronic use of systemic corticosteroids.
    Lacarrubba F; Dall'oglio F; Micali G
    G Ital Dermatol Venereol; 2011 Apr; 146(2):164-5. PubMed ID: 21505403
    [No Abstract]   [Full Text] [Related]  

  • 18. Lapatinib and ixabepilone for the treatment of metastatic breast cancer.
    Halterman PA
    Pharmacotherapy; 2008 Oct; 28(10):1255-66. PubMed ID: 18823221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A questionnaire survey about hair loss after chemotherapy for breast cancer].
    Oshima Y; Watanabe T; Nakagawa S; Endo A; Shiga C
    Gan To Kagaku Ryoho; 2012 Sep; 39(9):1375-8. PubMed ID: 22996772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical cutaneous vasculitis under lapatinib.
    Peuvrel L; Quereux G; Brocard A; Saint-Jean M; Freour E; Josselin N; Audouin AF; El Kouri C; Dreno B
    Eur J Dermatol; 2013; 23(4):540-1. PubMed ID: 23965414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.